Építés alatt – nem éles oldal
Belépés

What researchers published on Krónikus mieloid leukémia (CML)

8374 papers, newest first.

Showing 40 of 8374

  • ÁttekintésLeukemia as the price of immunity? An evolutionary cost framework.Frontiers in cell and developmental biology
  • ÁttekintésTreatment-Free Remission in Chronic Myeloid Leukemia: A Systematic Review of Predictors of Successful Tyrosine Kinase Inhibitor Discontinuation.Cureus
  • Intracranial Hemorrhage as the Initial Presentation of Chronic-Phase Chronic Myeloid Leukemia in an Adolescent.Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Correction to 'Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study'.British journal of haematology
  • Szisztematikus áttekintésClinical efficacy and safety of asciminib in chronic myeloid leukemia-chronic phase (CML-CP) in real-world settings: a systematic literature review.BMC cancer
  • Clinical characteristics and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: A final report of CML Cooperative Study Group.Leukemia research
  • Correction to: Patients' and healthcare providers' views regarding dose reduction of tyrosine kinase inhibitors in chronic myeloid leukemia: a qualitative study.The oncologist
  • Role and mechanism of ribosomal protein S3 in tyrosine kinase inhibitor resistance in chronic myeloid leukemia.Frontiers in oncology
  • Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Development, validation, and pilot-testing of a comprehensive patient-reported EORTC custom questionnaire for monitoring real-world tyrosine kinase toxicity in chronic myeloid leukemia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • Clonal hematopoiesis in long-term survivors after allogeneic hematopoietic cell transplantation: associations with active chronic graft-versus-host disease, donor age, and transplantation for chronic myeloid leukemia.Haematologica
  • Genomic and transcriptomic features associated with responses and outcomes of third-generation tyrosine kinase-inhibitor therapy in chronic myeloid leukemia.Leukemia
  • Is Bone Marrow Examination Still Required at Diagnosis of Typical Chronic-Phase Chronic Myeloid Leukemia? Evidence From Paired Peripheral Blood and Bone Marrow Cytogenetics.American journal of hematology
  • ÁttekintésPredictive factors for TKI discontinuation eligibility and treatment-free remission in chronic myeloid leukemia.International journal of hematology
  • Pharmacological SOS1 inhibitor BI-3406 synergizes with BCR::ABL1 TKIs reducing leukemia stem cells and overcoming imatinib resistance in CML.Cell death & disease
  • Differential regulation of PRSS57 by tyrosine kinase inhibitors and ATRA in myeloid leukaemia cells: an in vitro study.Journal of applied genetics
  • Investigation of selected MiRNA as potential biomarker in chronic myeloid leukemia patients.Medicine and pharmacy reports
  • Capillary dried plasma microsampling: A novel approach for therapeutic drug monitoring of tyrosine kinase inhibitors in chronic myeloid leukemia patients by UPLC-MS/MS.Journal of pharmaceutical and biomedical analysis
  • Correction: Target inhibition of CBP induced cell senescence in BCR-ABL- T315I mutant chronic myeloid leukemia.Frontiers in oncology
  • Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: long-term efficacy and endocrine analysis.Blood advances
  • EsetismertetésProlonged indolent clinical course in a high-risk chronic phase-CML patient without cytogenetic or molecular response: a case challenging established response paradigms.Annals of hematology
  • Aptamers in cancer research: Focus on leukemia.Chinese medical journal
  • A novel SLTM::RUNX1 acquired during CML progression and the clinical significance of concurrent BCR::ABL1 and RUNX1 rearrangements in Ph-positive leukemia.Cancer genetics
  • Relcobatinib, a highly selective ATP-competitive ABL1 tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.Leukemia
  • Prospective Evaluation of Hepatitis B Virus Reactivation in Cancer Patients Receiving Tyrosine Kinase Inhibitors.Journal of medical virology
  • ÁttekintésEmerging BCR::ABL1 inhibitors in chronic myeloid leukemia: current advances and future directions.International journal of hematology
  • EsetismertetésChronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report.Cureus
  • ANGPT1-based targeted drug screening: Identification of Tasosartan and its activity against tyrosine kinase inhibitor resistance in chronic myeloid leukemia.The Journal of international medical research
  • Assessment of Interpatient and Intrapatient Variability of Dasatinib and Imatinib Concentrations in Patients With Chronic Myeloid Leukemia via Volumetric Absorptive Microsampling at Home.Therapeutic drug monitoring
  • EsetismertetésBone Marrow Aplasia Under Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Rare and Unpredictable Complication.Cureus
  • Treatment-free remission after bosutinib discontinuation (BOSUTFR): results from a multicenter real-world study by the Spanish CML group.Annals of hematology
  • Áttekintés[Treatment strategies for chronic-phase chronic myeloid leukemia in 2026].[Rinsho ketsueki] The Japanese journal of clinical hematology
  • ÁttekintésChronic Myeloid Leukemia Beyond BCR::ABL1 Inhibition: Resistance Mechanisms and Emerging Therapeutic Modalities.Pharmaceuticals (Basel, Switzerland)
  • Leukostasis-related retinopathy as the initial presentation of chronic-phase chronic myeloid leukaemia.BMJ case reports
  • EsetismertetésPeritoneal Tuberculosis and Chronic Myeloid Leukaemia: A Case of Hickam's Dictum.The Medical journal of Australia
  • Predictive Value of the Zhang Scoring System for Imatinib Failure in Chronic Myeloid Leukemia: A Comparative Analysis with Established Prognostic Models.Turkish journal of haematology : official journal of Turkish Society of Haematology
  • Exploring the potential of vamotinib in Ph+ leukemias: is it indeed a 3rd generation tyrosine kinase-inhibitor?Journal of hematology & oncology
  • Imatinib Resistance in Chronic Myeloid Leukemia Is Associated with Distinct Metabolic, Oxidative, and Autophagic Adaptations in K562-Derived Cell Sublines.Biomedicines
  • Profiling Tyrosine Kinase Inhibitor-Specific Signatures of Homocysteine Metabolism and Mineral Homeostasis in Chronic Myeloid Leukemia.Asian Pacific journal of cancer prevention : APJCP
  • scDRP: disentangled representation learning for predicting single-cell responses to perturbations and estimating individual treatment effects.Briefings in bioinformatics